Superior Performance Of Hologic's Selenia Direct Digital Mammography Over Film Mammography
Hologic published the first large scale study comparing the results of a particular digital mammography technology to women screened with film.
|
Acrylamide not linked to breast cancer in U.S. women
Foods that contain acrylamide are unlikely to cause breast cancer in women.
|
Cardiff University Conducts World-Leading Breast Cancer Research
Cardiff University is at the forefront in the fight against breast cancer with cutting-edge research which could lead to better treatments for the disease.
|
Phase 1 Study Of Lapuleucel-T In Advanced Breast Cancer Patients Is Promising
Dendreon Corporation published results from a Phase 1 study f NEUVENGE, an investigational active cellular immunotherapy for breast cancer patients.
|
Dense Breasts, Hormone Levels Are Two Separate, Independent Risk Factors For Breast Cancer
Risk factors of breast cancer are not linked as previously assumed.
|
Mechanisms that silence the estrogen receptor gene alpha in certain breast cancer cell lines
Researchers may have unlocked the mechanisms that silence the estrogen receptor gene alpha during breast cancer.
|
NCI Cancelled Breast Cancer Prevention Drug Trial
National Cancer Institute cancelled a study designed to test the new class of breast cancer prevention drugs known as aromatase inhibitors.
|
Concord Grape Juice May Provide Protection Against Breast Cancer
According to a new study natural compounds in Concord grape juice protected healthy human breast cells from DNA damage.
|
Breast Cancer Survivors Carry Optimistic Outlook On Life
The majority of breast cancer survivors consider themselves stronger after having the disease.
|
New Guidelines Promise Better Results In Breast Cancer Care
International guidelines for the detection, care and management of breast cancer are now available in Spanish.
|
Rush University To Treat Breast Cancer With New Electronic Brachytherapy System
Women with early stage breast cancer now have a new treatment option available to help reduce recurrence of the disease using a miniaturized X-ray source.
|
New Radiation Technique Reduces Breast Cancer Treatment Side Effects
Women with early stage breast cancer who receive a newer type of radiation called intensity modulated radiation therapy develop significantly fewer side effects.
|
Proceeds From Televised Fundraiser To Benefit In Fight Against Breast Cancer
Rena Rowan Breast Center was one of the beneficiaries of the televised fundraiser that supports breast cancer research and patient education.
|
Researchers Identify Gene Involved In Breast Cancer
Researchers have identified a gene linked to the development of an aggressive form of breast cancer.
|
Method Provides Pre-Surgery Chemotherapy To Breast Cancer Patients
Treating a breast cancer patient with chemotherapy before breast cancer surgery does not harm the woman's health.
|
FDA Approves Eli Lilly's Osteoporosis Drug Evista To Prevent Breast Cancer
FDA recommending that Eli Lilly's bone-strengthening drug raloxifene, sold under the brand-name Evista, be approved to reduce the risk of breast cancer.
|
FDA Approves EVISTA For Reduction Of Risk For Invasive Breast Cancer
FDA voted to recommend approval of Eli Lilly and Company's osteoporosis drug EVISTA for a new use to reduce invasive breast cancer risk.
|
FDA To Consider Approving Eli Lilly's Osteoporosis Drug Evista To Be Used To Prevent Breast Cancer
FDA will consider whether Eli Lilly's bone-strengthening drug raloxifene should be approved to reduce the risk of breast cancer in some women.
|
Love - And Sex - Often Continue When Breast Cancer Returns
Breast cancer survivors whose disease has returned can maintain loving relationships and fulfilling sexual lives.
|
Diet High In Fruits, Vegetables Does Not Increase Breast Cancer Survival Rates
A diet that surpasses government recommendations for daily servings of fruits and vegetables does not boost breast cancer survival rates in women.
|
FDA Approves First Molecular-Based Lab Test To Detect Metastatic Breast Cancer
FDA approved the first molecular-based laboratory test for detecting whether breast cancer has spread (metastasized) to nearby lymph nodes.
|
High Fiber or Low Fat Diets Don't Prevent Breast Cancer Recurrence
High Fiber Or Low Fat Diet Does Not Appear to Reduce Risk of Breast Cancer Recurrence More Than '5-A-Day' Diet.
|
Women With Breast Cancer Carrying BRCA Genetic Mutations Have Similar Survival, As Noncarriers
Women diagnosed with breast cancer carrying the BRCA1 or BRCA2 gene mutations have similar survival and death rates as women not carrying the mutations.
|
PrivacyWear Defines A Lifestyle With Divas For A Breast Cancer Cure
A group of motorcycle "Divas" will take to the road this summer, traveling across the country promoting early detection, breast cancer awareness.
|
Candles Provide A SHIMMER OF HOPE In Curing Breast Cancer
Nature's Finest Candles will join Komen for the Breast Cancer Cure in this fight by offering a SHIMMER OF HOPE.
|
Studies Address Presence Of More Lethal Breast Cancer Among Black Women
Black women are more likely to develop breast cancer tumors.
|
State Department To Ignite Breast Cancer Awareness And Research In Latin America
Susan G. Komen for the Cure is part of the Partnership for Breast Cancer Awareness and Research of the Americas.
|
Breast cancers more aggressive in African-American women
African American women tend to have breast cancer tumor types that are more aggressive and have poorer prognoses.
|
MRI Plus X-Ray Mammography Doubles Breast Cancer Detection
For women at high risk of breast cancer, use of magnetic resonance imaging (MRI) plus X-ray mammography for screening will detect more breast cancers than mammography alone.
|
Ixabepilone Demonstrated Clear Activity In Patients With Metastatic Breast Cancer
Ixabepilone has activity in patients with metastatic breast cancer whose tumors were resistant to three types of standard chemotherapy (anthracycline, taxane, and capecitabine).
|
Breast Cancer Risk Higher Among Black Women Who Experienced Racial Discrimination
Black women who feel they have been racially discriminated against are more likely to develop breast cancer.
|
Why Black Women Have Higher Rates Of Aggressive Breast Cancer?
Young black women are more likely than white women to develop an aggressive form of breast cancer.
|
Study To Test New Generation Of Breast Cancer Drugs canceled
National Cancer Institute canceled a five-year, $100 million study designed to test the new class of breast cancer prevention drugs known as aromatase inhibitors.
|
Mammograms Identify 20% Of Breast Cancer Cases In Japanese Women
Mammograms have identified only 20% of breast cancer cases among Japanese women.
|
Breast cancer gene testing may be appropriate for more young breast cancer patients
Current models for recommending breast cancer gene testing can miss women with few older female relatives.
|
Women Well-Informed About Breast Cancer, Yet Lacking Knowledge About Current Treatments
While the majority (76 percent) of women surveyed said they know at least a fair amount about breast cancer, many remain unaware of the important recent progress made in treatment.While the majority (76 percent) of women surveyed said they know at least a fair amount about breast cancer, many remain unaware of the important recent progress made in treatment.
|
FDA Approves Clinical Trials Of Rexin-G For Breast Cancer And Sarcoma
Epeius Biotechnologies Corporation announced the expansion of ongoing clinical trials using Rexin-G to include breast cancer and all types of sarcomas that have failed standard chemotherapy.
|
Phase III Ixabepilone Study Demonstrated Improvement In Patients With Advanced Metastatic Breast Cancer
Bristol-Myers Squibb reported results from a large randomized Phase III study of the investigational compound ixabepilone in patients with breast cancer whose disease had rapidly progressed through, or did not respond to, prior treatment with chemotherapies.
|
CAELYX Delays Time To Metastatic Breast Cancer Progression
Results from a Phase III study that showed maintenance chemotherapy with CAELYX significantly prolonged time to progression in patients with metastatic breast cancer with infrequent and manageable clinical toxicity after first-line chemotherapy.
|
Xeloda - Avastin Combination Delays Breast Cancer Progression
Results of the XCALIBr trial showed that oral Xeloda in combination with Avastin effectively delayed time to disease progression in metastatic breast cancer patients with no prior history of treatment.
|
